ArticleJTCVS techniques2025
Surgical outcomes of cardiac fibroma in children: Early results.
Article in JTCVS techniques, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Arrhythmic risk in ventricular cardiac tumors: A comparative imaging and clinical analysis.American heart journal plus : cardiology research and practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To describe our surgical techniques and early outcomes after resection of cardiac fibromas in symptomatic children. Methods: A retrospective analysis was performed including all patients who underwent surgical resection of cardiac fibroma at a single institution between May 2021 and April 2024. Parameters reviewed were age, weight, genetic predisposition, clinical presentations, and results of investigations, including 3-dimensional virtual reality imaging. Completeness of resection, intraoperative complications, immediate postoperative outcomes and follow-up parameters including redo operations, arrhythmias, and mortality were analyzed. Results: The median age at surgery was 12 months (interquartile range [IQR], 8-129 months), and the median weight was 8.7 kg (IQR, 7.5-48.1 kg). The most common clinical presentation was ventricular arrhythmia (n = 5), and the left ventricular chamber was involved in all cases. Transmural resection was done in 5 cases, and complete resection was possible in 3. The cavity after resection was obliterated by layered closure using polypropylene. Loop recorders were implanted simultaneously in 4 cases. All patients had normal sinus rhythm at discharge, and the mean left ventricular ejection fraction was 55 ± 7%. The median duration of follow-up was 12 months (IQR, 11-32 months). One patient had recurrent arrhythmia and underwent reoperation owing to growth of the residual tumor. One patient with incomplete resection required implantation of an implantable cardioverter-defibrillator at 30 months after surgery. All patients were on anti-arrhythmic drugs and had a normal ECG on loop recorder analysis. Conclusions: Complete resection of cardiac fibroma is preferred but can be limited by tumor location. Arrhythmia-free survival can be achieved in most cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.